[ Price : $8.95]
FDA issues a draft guidance with recommendations for how companies can present quantitative efficacy and risk information in DTC h...[ Price : $8.95]
FDA approves Pfizers Talzenna (talazoparib), a poly (ADP-ribose) polymerase inhibitor for certain patients with locally advanced o...[ Price : $8.95]
FDA outlines a three-factor approach it uses to evaluate whether a drug- or device-related product communication is consistent wit...[ Price : $8.95]
FDA rejects a TearLab Corp. 510(k) for its TearLab Discovery MMP-9 test for dry eye disease.[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Hanlim Pharm Co. and Ignatius P. Godoy.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Rare Diseases: Early Drug Development and the Role of Pre-I...[ Price : $8.95]
FDA classifies as a Class 1 recall an Endologix safety notice to healthcare professionals about its AFX Endovascular AAA [abdomina...[ Price : $8.95]
FDA clears a Civco Radiotherapy 510(k) for its Solstice SRS Immobilization System.